These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 21908585)

  • 21. Outcomes after implantation of partial-support left ventricular assist devices in inotropic-dependent patients: Do we still need full-support assist devices?
    Sabashnikov A; Popov AF; Bowles CT; Mohite PN; Weymann A; Hards R; Hedger M; Wittwer T; Wippermann J; Wahlers T; Schoendube FA; Simon AR
    J Thorac Cardiovasc Surg; 2014 Sep; 148(3):1115-21; discussion 1021-2. PubMed ID: 25129605
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of a quality of life measure for left ventricular assist device recipients using a mixed methods approach.
    Slade AL; McMullan C; Haque MS; Griffith S; Marley L; Quinn D; O'Hara ME; Horton M; Calvert MJ; Lim HS; Lane DA
    ESC Heart Fail; 2024 Oct; 11(5):3167-3179. PubMed ID: 38873750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Implant Strategy-Specific Changes in Symptoms in Response to Left Ventricular Assist Devices.
    Lee CS; Gelow JM; Chien CV; Hiatt SO; Bidwell JT; Denfeld QE; Grady KL; Mudd JO
    J Cardiovasc Nurs; 2018; 33(2):144-151. PubMed ID: 28591005
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurohormonal regulation and improvement in blood glucose control: reduction of insulin requirement in patients with a nonpulsatile ventricular assist device.
    Koerner MM; El-Banayosy A; Eleuteri K; Kline C; Stephenson E; Pae W; Ghodsizad A
    Heart Surg Forum; 2014 Apr; 17(2):E98-102. PubMed ID: 24808450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Left Ventricular Assist Devices for Destination Therapy: A Health Technology Assessment.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2016; 16(3):1-60. PubMed ID: 27026798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Significance of Residual Mitral Regurgitation After Continuous Flow Left Ventricular Assist Device Implantation.
    Kassis H; Cherukuri K; Agarwal R; Kanwar M; Elapavaluru S; Sokos GG; Moraca RJ; Bailey SH; Murali S; Benza RL; Raina A
    JACC Heart Fail; 2017 Feb; 5(2):81-88. PubMed ID: 28017353
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Psychological distress in patients with a left ventricular assist device and their partners: an exploratory study.
    Brouwers C; Denollet J; Caliskan K; de Jonge N; Constantinescu A; Young Q; Kaan A; Pedersen SS
    Eur J Cardiovasc Nurs; 2015 Feb; 14(1):53-62. PubMed ID: 24351334
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Quality of life and mental health of patients with severe heart failure with or without technical support for the left cardiac ventricle - a cross-sectional study].
    Dahrmann B; Sindermann J; Geldmacher T; Heuft G
    Z Psychosom Med Psychother; 2017 Dec; 63(4):388-404. PubMed ID: 29214945
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The association of pretransplant HeartMate II left ventricular assist device placement and heart transplantation mortality.
    Donneyong M; Cheng A; Trivedi JR; Schumer E; McCants KC; Birks EJ; Slaughter MS
    ASAIO J; 2014; 60(3):294-9. PubMed ID: 24614355
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of left ventricular assist device (HeartMate II): a Singapore experience.
    Lim CP; Sivathasan C; Tan TE; Lim CH; Kerk KL; Sim DK
    Artif Organs; 2014 Jul; 38(7):543-8. PubMed ID: 24392937
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preoperative Pectoralis Muscle Quantity and Attenuation by Computed Tomography Are Novel and Powerful Predictors of Mortality After Left Ventricular Assist Device Implantation.
    Teigen LM; John R; Kuchnia AJ; Nagel EM; Earthman CP; Kealhofer J; Martin C; Cogswell R
    Circ Heart Fail; 2017 Sep; 10(9):. PubMed ID: 28912261
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiology, management, and outcomes of sustained ventricular arrhythmias after continuous-flow left ventricular assist device implantation.
    Raasch H; Jensen BC; Chang PP; Mounsey JP; Gehi AK; Chung EH; Sheridan BC; Bowen A; Katz JN
    Am Heart J; 2012 Sep; 164(3):373-8. PubMed ID: 22980304
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
    John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Perceptions of Important Elements of Caregiving for a Left Ventricular Assist Device Patient: A Qualitative Meta-Synthesis.
    Magid M; Jones J; Allen LA; McIlvennan CK; Magid K; Thompson JS; Matlock DD
    J Cardiovasc Nurs; 2016; 31(3):215-25. PubMed ID: 25882647
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Left ventricular assist device destination therapy versus extended criteria cardiac transplant.
    Daneshmand MA; Rajagopal K; Lima B; Khorram N; Blue LJ; Lodge AJ; Hernandez AF; Rogers JG; Milano CA
    Ann Thorac Surg; 2010 Apr; 89(4):1205-9; discussion 1210. PubMed ID: 20338335
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A conceptual definition of quality of life with a left ventricular assist device: results from a qualitative study.
    Sandau KE; Hoglund BA; Weaver CE; Boisjolie C; Feldman D
    Heart Lung; 2014; 43(1):32-40. PubMed ID: 24239297
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ventricular reconditioning and pump explantation in patients supported by continuous-flow left ventricular assist devices.
    Frazier OH; Baldwin AC; Demirozu ZT; Segura AM; Hernandez R; Taegtmeyer H; Mallidi H; Cohn WE
    J Heart Lung Transplant; 2015 Jun; 34(6):766-72. PubMed ID: 25447571
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quality of life and psychological well-being during and after left ventricular assist device support.
    Wray J; Hallas CN; Banner NR
    Clin Transplant; 2007; 21(5):622-7. PubMed ID: 17845636
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Implications of Transitional Care Interventions on Hospital Readmissions in Patients With Destination Therapy Left Ventricular Assist Devices.
    Iseler JI; Wierenga KL; Shaid EC; Hirschman K
    Res Theory Nurs Pract; 2019 Feb; 33(1):81-96. PubMed ID: 30796149
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Left ventricular assist device as destination for patients undergoing intravenous inotropic therapy: a subset analysis from REMATCH (Randomized Evaluation of Mechanical Assistance in Treatment of Chronic Heart Failure).
    Stevenson LW; Miller LW; Desvigne-Nickens P; Ascheim DD; Parides MK; Renlund DG; Oren RM; Krueger SK; Costanzo MR; Wann LS; Levitan RG; Mancini D;
    Circulation; 2004 Aug; 110(8):975-81. PubMed ID: 15313942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.